+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Angiopoietin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Renin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Angiotensin Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non Selective COX Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non Selective COX Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prostaglandin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Prostaglandin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leukotriene D4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more